Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action.
Methylphenidate (MPH), commercially called Ritalin or Concerta, has been widely used as a drug for Attention Deficit Hyperactivity Disorder (ADHD). Noteworthily, growing numbers of young people using prescribed MPH improperly for pleasurable enhancement, take high risk of addiction. Thus, understand...
Guardado en:
Autores principales: | Chun-Lei Zhang, Ze-Jun Feng, Yue Liu, Xiao-Hua Ji, Ji-Yun Peng, Xue-Han Zhang, Xue-Chu Zhen, Bao-Ming Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/af19d4ff4f3744079e968d9de70655b5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Social adjustment and family function after drug switch from IR -methylphenidate to OROS-methylphenidate in patients with attention-deficit/hyperactivity disorder
por: Chou WJ, et al.
Publicado: (2018) -
Changes in behavior as side effects in methylphenidate treatment: review of the literature
por: Konrad-Bindl DS, et al.
Publicado: (2016) -
Management of attention-deficit hyperactivity disorder in adults: focus on methylphenidate hydrochloride
por: Rajasree Nair, et al.
Publicado: (2009) -
Sphingosine-1-phosphate receptor 3 in the medial prefrontal cortex promotes stress resilience by reducing inflammatory processes
por: Brian F. Corbett, et al.
Publicado: (2019) -
Methylphenidate dose optimization for ADHD treatment: review of safety, efficacy, and clinical necessity
por: Huss M, et al.
Publicado: (2017)